Virax Biolabs Group Limited (NASDAQ:VRAX) Sees Large Decrease in Short Interest
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 158,600 shares, a decline of 21.7% from the February 28th total of 202,600 shares. Based on an average daily trading volume, of 377,700 shares, the […]
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 158,600 shares, a decline of 21.7% from the February 28th total of 202,600 shares. Based on an average daily trading volume, of 377,700 shares, the […]
